Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 10—October 2019
Research

Early Diagnosis of Tularemia by Flow Cytometry, Czech Republic, 2003–20151

Aleš ChrdleComments to Author , Pavlína Tinavská, Olga Dvořáčková, Pavlína Filipová, Věra Hnetilová, Pavel Žampach, Květoslava Batistová, Václav Chmelík, Amanda E. Semper, and Nick J. Beeching
Author affiliations: České Budějovice Hospital, České Budějovice, Czech Republic (A. Chrdle, P. Tinavská, P. Filipová, V. Hnetilová, P. Žampach, V. Chmelík); University of South Bohemia Faculty of Health and Social Sciences, České Budějovice, Czech Republic (A. Chrdle, O. Dvořáčková); Royal Liverpool University Hospital, Liverpool, UK (A. Chrdle, N.J. Beeching); Písek Hospital, Písek, Czech Republic (K. Batistová); Public Health England, Porton Down, UK (A.E. Semper); National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, UK (A.E. Semper; N.J. Beeching); Liverpool School of Tropical Medicine, Liverpool (N.J. Beeching)

Main Article

Figure 7

Comparison of time to first positive serologic test result for tularemia and time to raised CD3+/CD4–/CD8– T-cell percentage determined by flow cytometry relative to the time of symptom onset of 58 patients with probable or confirmed tularemia, Czech Republic, 2003–2015. Percentages of CD3+/CD4–/CD8– T cells >8% were considered raised. A positive serologic test result for tularemia was defined for probable cases as an antibody titer of >1:20 in any acute phase blood sample and for confirme

Figure 7. Comparison of time to first positive serologic test result for tularemia and time to raised CD3+/CD4–/CD8– T-cell percentage determined by flow cytometry relative to the time of symptom onset of 58 patients with probable or confirmed tularemia, Czech Republic, 2003–2015. Percentages of CD3+/CD4–/CD8– T cells >8% were considered raised. A positive serologic test result for tularemia was defined for probable cases as an antibody titer of >1:20 in any acute phase blood sample and for confirmed cases as a single antibody titer of >1:160 in any blood sample or a seroconversion from negative to positive (any titer) or a 4-fold increase in titer between acute and convalescent patient samples (agglutination test; Tularemia Diagnostic Set, Bioveta a.s., https://www.bioveta.eu). Boxes indicate interquartile ranges (IQRs), horizontal lines within boxes indicate medians, whiskers indicate range values <1.5× the IQR limits, and circles indicate outliers (i.e., values >1.5× times the IQR limits). The CD3+/CD4–/CD8– T cells increased before Francisella tularensis–specific antibody titers increased (Wilcoxon signed rank test, p<0.0001).

Main Article

1Preliminary data from this study were presented at the European Congress of Clinical Microbiology and Infectious Diseases; April 9–12, 2016; Amsterdam, the Netherlands (abstract no. O367).

Page created: September 17, 2019
Page updated: September 17, 2019
Page reviewed: September 17, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external